Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |